2017 Advances in Minimal Residual Disease (MRD) Testing in Multiple Myeloma
June 21, 2017
June 21, 2017
NORWALK, Conn., June 21 -- The Multiple Myeloma Research Foundation issued the following news release:
Last Friday, the MMRF and Memorial Sloan Kettering Cancer Center (MSKCC) co-hosted the Advances in Minimal Residual Disease (MRD) Testing in Multiple Myeloma meeting. This meeting, the fourth in the series, brought together 70 representatives from the MMRF, academia, the pharmaceutical industry, and government agencies to discuss progress in the last year toward standardization a . . .
Last Friday, the MMRF and Memorial Sloan Kettering Cancer Center (MSKCC) co-hosted the Advances in Minimal Residual Disease (MRD) Testing in Multiple Myeloma meeting. This meeting, the fourth in the series, brought together 70 representatives from the MMRF, academia, the pharmaceutical industry, and government agencies to discuss progress in the last year toward standardization a . . .